Autoimmune Disease Diagnostics Market by Testing Methods (Antinuclear Antibody Tests, Autoantibody Tests, C-Reactive Protein, Complete Blood Count, Comprehensive Metabolic Panel, Erythrocyte Sedimentation Rate, Urinalysis) and Applications (Grave’s Disease, Hashimoto’s Thyroiditis, Multiple Sclerosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Type 1 Diabetes) and Forecast 2017-2021

Autoimmune Disease Diagnostics Market by Testing Methods (Antinuclear Antibody Tests, Autoantibody Tests, C-Reactive Protein, Complete Blood Count, Comprehensive Metabolic Panel, Erythrocyte Sedimentation Rate, Urinalysis) and Applications (Grave’s Disease, Hashimoto’s Thyroiditis, Multiple Sclerosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Type 1 Diabetes) and Forecast 2017-2021

An autoimmune disease occurs when the body’s immune system begins to attack its own antigens. Autoimmune disease diagnostic tests can be defined as laboratory tests that are performed to diagnose autoimmune disorders. These tests include blood tests for one or more autoantibodies and tests for inflammation. Autoimmune disease laboratory testing involves complete blood count with differential, comprehensive metabolic panel, inflammatory markers, antinuclear antibodies, autoantibodies, CRP, ESR, urinalysis, and flow cytometry. The autoimmune disease diagnostics market is growing at a significant pace due to rise in the number of autoimmune patients, growing health care expenditure, and increase in demand for advanced diagnostic tests.

The global autoimmune disease diagnostics market report estimates the market size (Revenue USD million – 2014 to 2021) for market segmentation based on testing methods and their applications (Grave’s disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, Type 1 diabetes, etc.) and forecasts growth trends (CAGR% – 2017 to 2021).

The global autoimmune disease diagnostics market segmentation is based on geography (regional and country based). The global autoimmune disease diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global autoimmune disease diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global autoimmune disease diagnostics market and included in this report are F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, and Beckman Coulter, Inc.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Diagnostic Test Type
    • Indication or Infection Type
    • Technology
    • Diagnostics Application
    • Service Type
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Autoimmune Disease Diagnostics Market

1. Diagnostic Test
1.1. Antinuclear Antibody Tests
1.2. Autoantibody Tests
1.3. C-Reactive Protein (CRP)
1.4. Complete Blood Count (CBC)
1.5. Comprehensive Metabolic Panel
1.6. Erythrocyte Sedimentation Rate (ESR)
1.7. Urinalysis
1.8. Others

2. Disease Type
2.1. Graves’ Disease
2.2. Hashimoto’s Thyroiditis
2.3. Multiple Sclerosis
2.4. Rheumatoid Arthritis
2.5. Systemic Lupus Erythematosus
2.6. Type 1 diabetes
2.7. Others

3. Company Profiles
3.1. Abbott Laboratories, Inc.
3.2. Beckman Coulter, Inc.
3.3. bioMérieux SA
3.4. Bio-Rad Laboratories
3.5. F.Hoffmann-La Roche Ltd.
3.6. Inova Diagnostics, Inc.
3.7. Quest Diagnostics
3.8. Siemens Healthcare
3.9. SQI Diagnostics, Inc.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*

Translate »